ASP5878, a selective FGFR inhibitor, to treat FGFR3‐dependent urothelial cancer with or without chemoresistance

FGF/FGFR gene aberrations such as amplification, mutation and fusion are associated with many types of human cancers including urothelial cancer. FGFR kinase inhibitors are expected to be a targeted therapy for urothelial cancer harboring FGFR3 gene alternations. ASP5878, a selective inhibitor of FG...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Sci
Main Authors: Kikuchi, Aya, Suzuki, Tomoyuki, Nakazawa, Taisuke, Iizuka, Masateru, Nakayama, Ayako, Ozawa, Tohru, Kameda, Minoru, Shindoh, Nobuaki, Terasaka, Tadashi, Hirano, Masaaki, Kuromitsu, Sadao
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2017
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5329164/
https://ncbi.nlm.nih.gov/pubmed/27885740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13124
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares